National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Individuals who become alcohol dependent before age 25 are less likely to ever seek treatment than those who become alcohol dependent at age 30 or older, according to a new study supported by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health (NIH). They also are more likely to have multiple dependence episodes...

Friday, November 17, 2017, 11:00 am EST to Friday, November 17, 2017, 12:00 pm EST

Join the Addiction Policy Forum and the National Institute on Alcohol Abuse and Alcoholism (NIAAA) for a Facebook Live Event: Choosing Quality Alcohol Treatment: A Conversation With the Developers of the NIAAA Alcohol Treatment Navigator Speakers: Dr. Patricia Powell, NIAAA Deputy Director Dr. Lori Ducharme, Navigator Lead Developer Moderator: Mark O’Brien, VP of State and Local Affairs, Addiction Policy Forum...

Gregory Bloss, M.A., M.P.P./ Program Director, Division of Epidemiology and Prevention Research Acquisition Type/Actions The National Institute on Alcohol Abuse and Alcoholism (NIAAA) requests approval from the NIAAA Advisory Council to allow Research Triangle Institute (RTI) International to submit a contract proposal in response to a sole-source request for proposal. This acquisition, for other than full and open competition...

At some time during their lives, more than 30 percent of U.S. adults surveyed in 2001-2002 had met current diagnostic criteria [i] for an alcohol use disorder (AUD), according to an article in the current issue of the Archives of General Psychiatry . Many of those persons never received treatment, and many others did not receive treatment until well after...

March 26-27, 2018 Food and Drug Administration Great Room – White Oak Campus 10903 New Hampshire Ave., Silver Spring, MD Link for watching the workshop remotely: https://collaboration.fda.gov/greatv/ Home General Info Agenda Accommodations and Logistics Contact Registration Our Sponsors General Information Clinical Trial Design and Endpoints for Alcoholic Hepatitis and other Alcohol-Associated Liver Diseases Link for watching the workshop remotely: https://collaboration.fda.gov/greatv/...

Fri, 02/10/2023 - 12:00

This article was first published in NIAAA Spectrum Volume 15, Issue 1. Drinking too much—whether on a single occasion or over many years—can take a serious toll on an individual’s health. Clinicians across the health care spectrum can play important roles in preventing and treating the harmful effects of alcohol. This role is particularly important among providers who manage patients...

Home General Info Agenda Accommodations and Logistics Contact Registration Recommended Reading Our Sponsors Name Information on: Email Deidra Roach, M.D. Scientific Contact or the Agenda droach@mail.nih.gov Lynn Morin Logistics lynn.morin@nih.gov

Kathy Jung, Ph.D., Mark Egli, Ph.D., Gary Murray, Ph.D. Reissuance of PAR 17 170 Alcohol Research Resource Awards (R24, Clinical Trial Not Allowed) Purpose The purpose of the Resource-Related Research Projects (R24, clinical trial not allowed) grant mechanism is to support investigator-initiated research resource projects that will provide resources to other investigators who conduct biomedical research appropriate to the mission...

A new study supported by the National Institutes of Health shows that individuals with alcohol use disorder (AUD) are less likely to receive antivirals for hepatitis C, despite current guidelines recommending antiviral treatment regardless of alcohol use. Direct-acting antiviral treatment is highly effective at reducing serious illness and death among individuals with hepatitis C virus (HCV) infection, a condition that...

Fri, 03/03/2023 - 12:00

This article was first published in NIAAA Spectrum Volume 15, Issue 1. Alcohol use disorder (AUD) is a heterogeneous disorder, meaning individuals with AUD differ in their clinical symptoms and in the biological and psychological factors that contribute to their disorder. A better understanding of individual differences in AUD could inform the development of tailored treatment approaches to increase treatment...

NIAAA encourages research to refine diagnosis, enhance treatment, sustain recovery, and ultimately, to reduce the treatment gap for alcohol use disorder and other alcohol-related health conditions.

New clinical research supported by the National Institutes of Health shows that increasing the intensity of treatment for alcohol use disorder (AUD) over time improves alcohol-related outcomes among people with HIV. This stepped approach to AUD treatment also improves HIV-related disease measures in this patient population. A report of the new study, led by researchers at Yale University, is now...

Home General Info Agenda Accommodations and Logistics Contact Registration Recommended Reading Our Sponsors Please click on the link below to register for this event: Registration Form Please note that due to limited space, we cannot accept more than 300 registrants. If you have any questions, technical or otherwise, regarding the registration form please contact Aamna Bhatti at aamna.bhatti@nih.gov

Sun, 09/20/2015 - 12:00

Sun, 09/20/2015 - 12:00

In a commentary published in April in the journal Alcoholism: Clinical and Experimental Research , Raye Litten, Ph.D., and other NIAAA scientists describe the evolution of our understanding of the heterogeneity of alcohol use disorder (AUD), and outline new treatment and research regimes that follow from the recognition that alcohol problems are manifested along a continuum of severity, ranging from...

Fri, 03/13/2020 - 12:00

Fri, 03/13/2020 - 12:00

Alcoholics Anonymous (AA) is as effective as established behavioral treatments for some people with alcohol use disorder (AUD), according to an extensive review of NIAAA-supported research and other studies. As reported March 11 in the Cochrane Database of Systematic Review , researchers used a meta-analysis to show that AA and other 12-step facilitation interventions are effective in helping individuals with...

Thu, 06/06/2019 - 12:00

Thu, 06/06/2019 - 12:00

Alcohol is involved in nearly half of all liver disease deaths in the United States each year. Alcohol-associated liver disease (AALD) now replaces hepatitis C viral infection as the lead cause of liver transplantation due to chronic liver disease. Consequently, there is an urgent need for effective interventions for AALD, a complex disease with multiple contributing factors. One of these...

November 4, 2019

Given the high co-occurrence between alcohol use disorder (AUD) and mental health conditions (MHCs) it is important that co-occurring disorders be addressed in integrated treatment. The latest article from Alcohol Research Current Reviews examines the prevalence of co-occurring AUD and MHCs, screening tools to identify individuals with symptoms of AUD and MHCs, and subsequent assessment of co-occurring disorders. Types of...

Tuesday, October 24, 2017, 1:00 pm EDT

Come talk w/ us and @ASAMorg about finding quality alcohol treatment - # TreatmentNavigator

March 26-27, 2018 Food and Drug Administration Great Room – White Oak Campus 10903 New Hampshire Ave., Silver Spring, MD Home General Info Agenda Accommodations and Logistics Contact Registration Our Sponsors Contact Bridgette Green, Logistics greenbd@mail.nih.gov Svetlana Radaeva, Scientific Contact or the Agenda sradaeva@mail.nih.gov Gyongyi Szabo, Scientific Contact or the Agenda Gyongyi.Szabo@umassmed.edu Link for watching the workshop remotely: https://collaboration.fda.gov/greatv/

Home General Info Agenda Accommodations and Logistics Contact Registration Recommended Reading Our Sponsors National Institute on Drug Abuse Substance Abuse and Mental Health Services Administration National Institutes of Health: Office of AIDS Research National Institutes of Health: Office of Research on Women's Health